Aju Ib Investment Co., Ltd. - Net Worth and Insider Trading
Aju Ib Investment Co., Ltd. Net Worth
The estimated net worth of Aju Ib Investment Co., Ltd. is at least $190,419 dollars as of 2024-11-10. Aju Ib Investment Co., Ltd. is the 10% Owner of Aileron Therapeutics Inc and owns about 50,509 shares of Aileron Therapeutics Inc (ALRN) stock worth over $190,419. Details can be seen in Aju Ib Investment Co., Ltd.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Aju Ib Investment Co., Ltd. has not made any transactions after 2017-07-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Aju Ib Investment Co., Ltd.
Aju Ib Investment Co., Ltd. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Aju Ib Investment Co., Ltd. owns 2 companies in total, including Apellis Pharmaceuticals Inc (APLS) , and Aileron Therapeutics Inc (ALRN) .
Click here to see the complete history of Aju Ib Investment Co., Ltd.’s form 4 insider trades.
Insider Ownership Summary of Aju Ib Investment Co., Ltd.
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| APLS | Apellis Pharmaceuticals Inc | 2017-11-08 | 10 percent owner |
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 10 percent owner |
Aju Ib Investment Co., Ltd. Latest Holdings Summary
Aju Ib Investment Co., Ltd. currently owns a total of 1 stock. Aju Ib Investment Co., Ltd. owns 50,509 shares of Aileron Therapeutics Inc (ALRN) as of July 5, 2017, with a value of $190,419.
Latest Holdings of Aju Ib Investment Co., Ltd.
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALRN | Aileron Therapeutics Inc | 2017-07-05 | 50,509 | 3.77 | 190,419 |
Holding Weightings of Aju Ib Investment Co., Ltd.
Aju Ib Investment Co., Ltd. Form 4 Trading Tracker
According to the SEC Form 4 filings, Aju Ib Investment Co., Ltd. has made a total of 0 transactions in Aileron Therapeutics Inc (ALRN) over the past 5 years. The most-recent trade in Aileron Therapeutics Inc is the acquisition of 1,246 shares on July 5, 2017, which cost Aju Ib Investment Co., Ltd. around $373,935.
Insider Trading History of Aju Ib Investment Co., Ltd.
- 1
Aju Ib Investment Co., Ltd. Trading Performance
GuruFocus tracks the stock performance after each of Aju Ib Investment Co., Ltd.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Aju Ib Investment Co., Ltd. is 18.28%. GuruFocus also compares Aju Ib Investment Co., Ltd.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Aju Ib Investment Co., Ltd. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Aju Ib Investment Co., Ltd.'s insider trading performs compared to the benchmark.
Performance of Aju Ib Investment Co., Ltd.
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.38 | | | | | |
| Relative Return to S&P 500(%) | -3.2 | | | | | |
Aju Ib Investment Co., Ltd. Ownership Network
Ownership Network List of Aju Ib Investment Co., Ltd.
Ownership Network Relation of Aju Ib Investment Co., Ltd.
Aju Ib Investment Co., Ltd. Owned Company Details
What does Apellis Pharmaceuticals Inc do?
Who are the key executives at Apellis Pharmaceuticals Inc?
Aju Ib Investment Co., Ltd. is the 10 percent owner of Apellis Pharmaceuticals Inc. Other key executives at Apellis Pharmaceuticals Inc include See Remarks James George Chopas , Chief Operating Officer Pascal Deschatelets , and Chief Financial Officer Timothy Eugene Sullivan .
Apellis Pharmaceuticals Inc (APLS) Insider Trades Summary
Over the past 18 months, Aju Ib Investment Co., Ltd. made no insider transaction in Apellis Pharmaceuticals Inc (APLS). Other recent insider transactions involving Apellis Pharmaceuticals Inc (APLS) include a net sale of 296,688 shares made by Pascal Deschatelets , a net sale of 463,087 shares made by Cedric Francois , and a net sale of 102,839 shares made by Timothy Eugene Sullivan .
In summary, during the past 3 months, insiders sold 37,742 shares of Apellis Pharmaceuticals Inc (APLS) in total and bought 0 shares, with a net sale of 37,742 shares. During the past 18 months, 1,263,451 shares of Apellis Pharmaceuticals Inc (APLS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,263,451 shares.
Apellis Pharmaceuticals Inc (APLS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Apellis Pharmaceuticals Inc Insider Transactions
Aju Ib Investment Co., Ltd. Mailing Address
Above is the net worth, insider trading, and ownership report for Aju Ib Investment Co., Ltd.. You might contact Aju Ib Investment Co., Ltd. via mailing address: 5f, Aju Building, 201 Teheran-ro, Gangnam-gu, Seoul M5 06141.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
